담즙정체가 동반된 환자에서 혈중 고밀도지질단백질 콜레스테롤 농도의 검사방법에 따라 차이를 보이는 증례에 대한 고찰
Cholestasis Causes Discrepancy in HDL-Cholesterol Levels Measured Using Various Methods
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
저자들은 쓸개즙 정체 환자에서 HDL 균질법 검사시약에 따라고밀도지질단백질 결과가 달랐던 증례를 보고하는 바이다. 이러한 결과 차이는 환자의 혈청에 비정상 지질단백질, 즉 apo E-rich HDL이 증가하였기 때문이었다. 지질단백질 전기이동에서는 느린α이동 띠가 관찰되었고, 저밀도지질단백질 소분획 검사에서는 입자의 크기가 큰 HDL이 관찰되었다. 혈청 아포지질단백질 E 농도는증가되어 있었다.
Abstract
Herein, we report a case in which cholestasis caused discrepancy in high-density lipoprotein (HDL)-cholesterol levels measured using various methods. The discrepancy in HDL-cholesterol level originated from the abnormal increase in the level of an unusual lipoprotein, apo E-rich HDL, in the patient’s serum. An abnormal slow alpha-migrating lipoprotein was observed on agarose gel electrophoresis, and an abnormal large-sized HDL was observed in a lipoprotein subfraction study. The level of apolipoprotein E was elevated.
참고문헌 (15)
- Min WK, "Factors affecting the difference between the low-density lipoprotein cholesterol concentrations measured directly and calculated using the friedewald formula", J Lab Med Qual Assur, 30, pp.233~235 (2008)
- 허미나, "균질법에 의한 저밀도지단배콜레스테롤의 측정 및 Frieddwald 계산법과의 비교", Annals of Laboratory Medicine, 23(2), pp.104~108 (2003), 대한진단검사의학회
- Remaley AT, "Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors, In Tietz textbook of clinical chemistry and molecular diagnostics. 5th ed", pp.731~805 (2012), Elsevier
- Remaley AT, "HDL-C. The changing testing paradigm part 1, In Clinical Laboratory News" (2007), American Association for Clinical Chemistry
- Clifton PM, "High density lipoprotein particle size distribution in subjects with obstructive jaundice", J Lipid Res, 29, pp.121~135 (1988)
- Coulhon MP, "Changes in human high density lipoproteins in patients with extra-hepatic biliary obstruction", Clin Chim Acta, 145, pp.163~172 (1985)
- Yamashita S, "Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency", J Clin Invest, 86, pp.688~695 (1990)
- Chiba H, "Spurious elevation of serum high-density lipoprotein cholesterol in patients with cholestatic liver diseases", Biochem Med Metab Biol, 46, pp.329~343 (1991)
- Tallet F, "Characterization of lipoproteins during human cholestasis", Clin Chim Acta, 244, pp.1~15 (1996)
- Black DD, "Chronic cholestasis and dyslipidemia: what is the cardiovascular risk?", J Pediatr, 146, pp.306~307 (2005)
- Werner A, "Fat absorption and lipid metabolism in cholestasis, In Madame Curie Bioscience Database" (2000), Landes Bioscience
- Claudel T, "Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element", J Clin Invest, 109, pp.961~971 (2002)
- Lund-Katz S, "High density lipoprotein structure-function and role in reverse cholesterol transport", Subcell Biochem, 51, pp.183~227 (2010)
- Krauss RM, "Lipoprotein subfractions and cardiovascular disease risk", Curr Opin Lipidol, 21, pp.305~311 (2010)
- Hopkins PC, "Evidence for differential effects of apoE3 and apoE4 on HDL metabolism", J Lipid Res, 43, pp.1881~1889 (2002)
